AU1085297A - Methods for optimizing multicomponent formulations - Google Patents

Methods for optimizing multicomponent formulations

Info

Publication number
AU1085297A
AU1085297A AU10852/97A AU1085297A AU1085297A AU 1085297 A AU1085297 A AU 1085297A AU 10852/97 A AU10852/97 A AU 10852/97A AU 1085297 A AU1085297 A AU 1085297A AU 1085297 A AU1085297 A AU 1085297A
Authority
AU
Australia
Prior art keywords
optimizing
methods
multicomponent formulations
multicomponent
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10852/97A
Inventor
Paul Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexstar Pharmaceuticals Inc
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Publication of AU1085297A publication Critical patent/AU1085297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU10852/97A 1995-11-29 1996-11-27 Methods for optimizing multicomponent formulations Abandoned AU1085297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US769495P 1995-11-29 1995-11-29
US007694 1995-11-29
PCT/US1996/019030 WO1997020076A1 (en) 1995-11-29 1996-11-27 Methods for optimizing multicomponent formulations

Publications (1)

Publication Number Publication Date
AU1085297A true AU1085297A (en) 1997-06-19

Family

ID=21727646

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10852/97A Abandoned AU1085297A (en) 1995-11-29 1996-11-27 Methods for optimizing multicomponent formulations

Country Status (2)

Country Link
AU (1) AU1085297A (en)
WO (1) WO1997020076A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6757667B1 (en) 2000-04-12 2004-06-29 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method for optimizing formulations
US6768973B1 (en) 2000-04-12 2004-07-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method for finding solutions
US6420178B1 (en) * 2000-09-20 2002-07-16 General Electric Company High throughput screening method, array assembly and system
EP1512970A1 (en) * 2003-09-05 2005-03-09 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method for determining the impact of a multicomponent mixture on the biological profile of a disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441745A (en) * 1982-03-30 1995-08-15 Vestar, Inc. Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
US5329029A (en) * 1992-11-05 1994-07-12 Wan Barbara Y Phosphatidylalkanolamine derivatives and their use in generating phospholipid conjugates

Also Published As

Publication number Publication date
WO1997020076A1 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU7265596A (en) Probiotically acting formulations
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU6235496A (en) Azothiophenes
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU5108596A (en) Morphine-3-esters
AU7038196A (en) 1-azinyl-tetrazolinones
AU2611695A (en) Sailboatsystem for controlled gibing
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU6215196A (en) Piperidinylmethyloxazolidinones
AU1085297A (en) Methods for optimizing multicomponent formulations
AU5013796A (en) Wireclamp
AU4682796A (en) Automatically downfolding slab
AU5107096A (en) Haemodialyser
AU6840796A (en) Sack-holder
AU7694696A (en) Cyclopeptolides
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU7565396A (en) Fluorobutenoyloxyacetamides